Investing Profile

Krishna Yeshwant

VCInvestor

Managing Partner at GV

gv.com/team/krishna-yeshwant/Boston, Massachusetts
Photo of Krishna Yeshwant, Managing Partner at GV

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
402 CONNECTIONS
Harvard Business School Network
283 CONNECTIONS
Google Network
245 CONNECTIONS
cb
GV Managing Partner
$250K - $50.0M
$25.0M
26
$100M
CompanyStageDateRound SizeTotal Raised
Xilis
Series AJul 2021$70M
$76M
Co-investors: Wesley Chan (FPV Fund)
Clear Labs
Series CMay 2021$60M
$120M
Co-investors: Aydin Senkut (Felicis Ventures), Greg Yap (Menlo Ventures), Kyle Kurpinski (Tencent Holdings)
Adagio Therapeutics
Series CApr 2021$340M
Series BNov 2020$80M
Series AJul 2020$50M
$470M
Co-investors: Terry McGuire (Polaris Partners)
Insitro
Series CMar 2021$400M
Series BMay 2020$140M
Series AMay 2018$100M
$740M
Co-investors: Vijay Pande (Andreessen Horowitz), Robert Nelsen (ARCH Venture Partners), Jim Tananbaum (Foresite Capital), Jay Markowitz (ARCH Venture Partners)
Verve Therapeutics
Series BJan 2021$94M
Series AJun 2020$63M
$160M
Co-investors: Eli Casdin (Casdin Capital)
Vera Therapeutics
Series CJan 2021$80M
Venture RoundSep 2019$34M
$110M
Co-investors: Maha Katabi (Sofinnova Investments), Kurt von Emster (Abingworth), Beth Seidenberg (Kleiner Perkins)
Fractyl Health
Series EAug 2020$55M
$55M
ROME Therapeutics
Series AApr 2020$50M
$130M
Co-investors: Steve Kafka (Section 32), Kristina Burow (ARCH Venture Partners), Jim Trenkle (Sanofi Ventures)
Attending Partners HealthCare2009 - Present
Partner Google Ventures2009 - Present
New Business Development Google2008 - 2009
IMSA
Stanford University
Harvard Business School MBA
Harvard Medical School Doctor of Medicine (MD)